As of 2025-02-18, the EV/EBITDA ratio of Dicerna Pharmaceuticals Inc (DRNA) is -22.81. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DRNA's latest enterprise value is 2,729.79 mil USD. DRNA's TTM EBITDA according to its financial statements is -119.65 mil USD. Dividing these 2 quantities gives us the above DRNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
Range | Selected | |
Trailing P/E multiples | 13.5x - 15.7x | 15.1x |
Forward P/E multiples | 16.7x - 23.2x | 21.0x |
Fair Price | (24.16) - (22.61) | (26.32) |
Upside | -163.2% - -159.2% | -168.9% |
Date | EV/EBITDA |